-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
CNBX Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q4 2011 to Q4 2023.
- CNBX Pharmaceuticals Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending November 30, 2023 was -$1.2K.
- CNBX Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $24.7K, a 2.09% decline from 2022.
- CNBX Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $25.2K, a 96.1% decline from 2021.
- CNBX Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $645K, a 80.4% decline from 2020.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)